Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e66070cbe19cee2a7e98dd43682126d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f20295e0039e262e0107e5b171a9ea4 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
filingDate |
2012-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fe101bbe5fa1884fa5ebe0be3eb0f44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43c16434a19a6265bd5bdb07bcd9634d |
publicationDate |
2013-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2771564-A1 |
titleOfInvention |
Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensitivity and radiosensitivity in tumor or cancer cells |
abstract |
Disclosed are methods of increasing the chemosensitivity of normal and/or chemoresistant tumor or cancer cells using thyroid hormone analogs and/or nanoparticulate or polymeric forms thereof. Also disclosed are methods of increasing radiosensitivity of normal and/or radioresistant tumor or cancer cells using thyroid hormone analogs and/or nanoparticulate or polymeric forms thereof. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111944746-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111944746-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112930212-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112899229-A |
priorityDate |
2012-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |